Today: 29 January 2026
Subscribe
Browse Category

Healthcare Stocks News 3 October 2025 - 25 November 2025

Exact Sciences (EXAS) Stock Today: Analyst Downgrades, Abbott’s $21 Billion Takeover and Legal Scrutiny – 25 November 2025

Exact Sciences (EXAS) Stock Today: Analyst Downgrades, Abbott’s $21 Billion Takeover and Legal Scrutiny – 25 November 2025

Exact Sciences Corporation (NASDAQ: EXAS) is trading near record highs as Wall Street shifts to “Hold,” merger-arb funds move in and shareholder lawyers start circling Abbott’s $21 billion bid. Exact Sciences Stock Price Snapshot for 25 November 2025 On Tuesday, 25 November 2025, Exact Sciences stock is trading around $101 per share, hovering just below its all‑time and 52‑week high…
25 November 2025
···
Exact Sciences (EXAS) Stock Today, November 24, 2025: Abbott Buyout Spread, Analyst Downgrades and UBS Target Hike

Exact Sciences (EXAS) Stock Today, November 24, 2025: Abbott Buyout Spread, Analyst Downgrades and UBS Target Hike

Dateline: November 24, 2025 Exact Sciences Corporation (NASDAQ: EXAS) stock is trading calmly near its takeover price today as Wall Street digests a flood of fresh analyst calls, legal scrutiny and local reaction to Abbott Laboratories’ multi‑billion‑dollar bid for the cancer‑diagnostics specialist. With shares hovering around $101 this afternoon and a cash offer on the table at $105 per share,…
24 November 2025
····
MOH Stock Today, Nov. 24, 2025: Molina Healthcare Rallies on ACA Subsidy Hopes as Lawsuits and Margin Pressures Linger

MOH Stock Today, Nov. 24, 2025: Molina Healthcare Rallies on ACA Subsidy Hopes as Lawsuits and Margin Pressures Linger

Molina Healthcare Inc. (NYSE: MOH) shares bounced higher on Monday as traders reacted to fresh headlines about a possible extension of Affordable Care Act (ACA) subsidies, even as the managed-care insurer continues to grapple with margin pressure, new class‑action lawsuits and a sharp rerating of its valuation. As of Monday’s close, MOH stock finished at $145.30, up about 2.6% for…
24 November 2025
·
Hims & Hers Health (HIMS) Stock Today, November 23, 2025: Price, Buyback and GLP‑1 Risks

Hims & Hers Health (HIMS) Stock Today, November 23, 2025: Price, Buyback and GLP‑1 Risks

Hims & Hers Health (NYSE: HIMS) heads into the new week as one of the market’s most closely watched telehealth and weight‑loss plays — but also one of its most volatile. After Friday’s session (21 November 2025), HIMS closed at $34.71, up about 3.2% on the day. That puts the stock roughly 43–44% higher year‑to‑date, yet still almost 50% below…
23 November 2025
···
EXAS Stock Soars on Abbott Takeover Talks: Exact Sciences Jumps Over 20% on November 19, 2025

EXAS Stock Soars on Abbott Takeover Talks: Exact Sciences Jumps Over 20% on November 19, 2025

Exact Sciences Corporation (NASDAQ: EXAS) is surging today after reports that healthcare giant Abbott Laboratories is in advanced talks to acquire the cancer diagnostics specialist. Shares of EXAS spiked sharply intraday, briefly approaching new 52‑week highs as traders rushed into the name on renewed takeover speculation.  Reuters Key points EXAS stock today: price, move, and trading activity According to Exact…
19 November 2025
····
Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Stock Hits All-Time High After Earnings Surprise Cardinal Health’s stock price surged to an all-time high on October 30, 2025, after the company delivered much better-than-expected quarterly results. Shares soared ~13% in one day, briefly trading above $190 intraday and settling around $185 – levels never seen before Investing 247Wallst. This spike extended Cardinal’s impressive rally (the stock is up…
30 October 2025
····
Molina Healthcare (MOH) Stock Plunges 18% on Earnings Shock – What’s Next?

Molina Healthcare (MOH) Stock Plunges 18% on Earnings Shock – What’s Next?

Q3 Earnings Shock Triggers Selloff Molina Healthcare’s third-quarter earnings report sparked a major selloff in its stock this week. The Medicaid and Obamacare-focused insurer delivered adjusted Q3 earnings of just $1.84 per share, far below analyst expectations of around $3.90 Reuters. On a GAAP basis, net income collapsed to $79 million ($1.51/share) from $326 million ($5.65/share) a year earlier Nasdaq…
23 October 2025
····
Intuitive Surgical (ISRG) Stock Explodes 17% on Q3 Blowout – Is $600 Next?

Intuitive Surgical (ISRG) Stock Explodes 17% on Q3 Blowout – Is $600 Next?

Q3 Earnings Blowout and Stock Reaction Intuitive Surgical crushed expectations for the quarter ended Sept 30, 2025. 3Q revenue was $2.51 billion, up 23% from a year ago, versus analyst forecasts of ~$2.40 billion Reuters. Adjusted EPS came in at $2.40 (GAAP $1.95), easily above the ~$1.99 consensus Reuters Globenewswire. The company reported $867 million in non-GAAP net income (versus $669 M a year…
22 October 2025
····
Intuitive Surgical Stock Primed for Rally on FDA Approvals and Congressional Buying

Intuitive Surgical Stock Primed for Rally on FDA Approvals and Congressional Buying

Stock Performance & Analyst Consensus Intuitive’s stock has been volatile in 2025. It gained ground last week on optimism (e.g. up ~2.7% on Oct. 17) and now sits around $446 Investing Marketbeat. Over the past year, the price swung between about $425 and $616 Investing. At ~$446, ISRG trades at a high single-digit P/E (~60x) compared to the medtech sector,…
19 October 2025
····
Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Price and Performance Abbott’s stock has been trading in a tight range around $128–$133 in mid-October 2025. On Oct 15, the price was about $128 – down 3.5% intraday Reuters. Over the past few trading days ABT fell from $131.38 (Oct 13 close) and $133.27 (Oct 14) to $128.77 Stockanalysis. In context, ABT’s YTD gain is roughly 18%, outpacing the…
15 October 2025
····
Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Skyrockets – Major News & Analyst Insights (Oct 2025)

Key Facts: Oscar Health’s stock recently jumped to roughly $21.5 on Oct 3, 2025 (up ≈11% that day) Indmoney. Over the past week, the stock is up about 8% Marketscreener. In Q2 2025, Oscar reported $2.9 billion revenue (+28–30% YoY) but a $228 million net loss ($0.89/share) due to a high medical loss ratio Tradingview. Management has reaffirmed full-year 2025 guidance (revenues…
3 October 2025
····
Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Stock Performance (Oct 3, 2025) As of this afternoon’s trading on Oct 3, Oscar Health shares are up ~2.8% around $19.81. The stock opened near $19.82 and is trading in a tight range (today’s low ~$19.80, high ~$19.95). Yesterday (Oct 2) it closed at $19.28 (+2.0%), continuing a rebound from late-September lows (it had hit ~$17 in mid-September). Volume so…
3 October 2025
·····
1 … 3 4 5 6

Stock Market Today

  • Eternal Ltd Shares Surge 8.47% After Hours on NSE with Volume Spike
    January 29, 2026, 12:57 PM EST. Eternal Ltd (ETERNAL.NS) shares jumped 8.47% to INR 275.35 in after-hours trading on 29 Jan 2026, with volume more than doubling to 74.3 million shares, signaling strong market interest. Despite lofty valuation metrics-P/E of 1,157.83 and price-to-sales of 5.66-the stock shows mixed technical signals; the ADX at 30.96 indicates a strong trend while RSI and CCI suggest cautious momentum. Meyka AI assigns a B (Hold) rating with a 23.54% price upside forecast to INR 340.16. Key catalysts include upcoming earnings and user growth, but stretched fundamentals and negative operating margin remain risks. The stock remains a high-activity title within the communication services sector, attracting momentum-led traders.
Go toTop